IPA enjoyed both full days of the Probiotics Congress USA in La Jolla near San Diego, California on October3-4th. And it was more than sunny days and probiotic-rich cuisine— kimchee, kefir and fermented mayonnaise–as the lineup included the 4th Microbiome R&D and Business Collaboration Forum; therefore, this enterprising assembly brought academics and industry stakeholders to the table.
Awareness in microbial ecosystems in animal and human health has led to a surge in research, publications and companies in the synbiotic space. The conference explored the development of the next generation of probiotics, prebiotics and functional foods and their impact of human health.
A real plus was the global flavor: speakers as well as attendees arrived from most continents, bringing unique perspectives. Another way this conference shone: diverse skillsets made for interesting chat.
- Translating the microbiome to medicine
- Developing next-generation bacteria for therapies
- Role of prebiotics in human health
- Probiotics in antibiotic-associated diarrhea (AAD) prevention
- Is the microbiome a cause or consequence of inflammatory skin diseases?
- Microbiome diagnostics for colon cancer prevention
- Microbes in lowering cholesterol
- Probiotics help the oral cavity across the lifespan
- Microbial drugs for lactose intolerance
- Venture capital in the microbiome space
- Probiotics and the epithelial barrier in the gut
- Vaginal microbiome and health
- Streptococcus salivarius against middle ear infections in children
- Microbiota and mental health
- Psychobiotics: pending studies
IPA will bring you news and video from the conference in the coming days.